Buscar
07/02/2025
25 years of providing evidence on road safety interventions at the city level
Pérez, K, Santamariña-Rubio, E, López, MJ, Artazcoz, L, Ferrando, J, Pastor, C, Hyder, AA, Borrell, C. 25 years of providing evidence on road safety interventions at the city level. Frontiers in Public Health. 2025; 12DOI:10.3389/fpubh.2024.1463878. PMID:39989864. IF:3.400(Q1/2D).
07/02/2025
Community Use and Perceptions of Climate Shelters in Schoolyards in Barcelona
Sanz-Mas, M, Continente, X, Marí-Dell'Olmo, M, López, MJ. Community Use and Perceptions of Climate Shelters in Schoolyards in Barcelona. International Journal of Public Health. 2025; 70DOI:10.3389/ijph.2025.1608083. PMID:39990015. IF:2.400(Q2/4D).
07/02/2025
Sprinkler irrigation of urban sport fields as a potential source of Legionella
Bosch, G, Queralt, A, Valero, N, Lleó, T, Portolés, C, Vargas-Leguas, H, Parra, E, Gonzalez, R, Rius, C, Gómez-Gutiérrez, A. Sprinkler irrigation of urban sport fields as a potential source of Legionella. Archives of Environmental & Occupational Health. 2025; 80(1-2)DOI:10.1080/19338244.2025.2451903. PMID:39874031. IF:0.900(Q4/9D).
04/02/2025
Anterior clinoid process metastasis with sudden loss of vision: role of emergency optic nerve decompression
Rico-Pereira, M, Muñoz-Hernández, F. Anterior clinoid process metastasis with sudden loss of vision: role of emergency optic nerve decompression. Egyptian Journal Of Neurosurgery. 2025; 40(1)DOI:10.1186/s41984-025-00371-3. PMID:. IF:(Q/D).
04/02/2025
Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
Bastos-Oreiro, M, Iacoboni, G, Garcés, VN, Caballero, AC, Martínez, N, Delgado, J, Balaguer, A, Kwon, M, de Villambrosia, S, Hernani, R, Jimenez-Ubieto, A, Bailen, R, Zaberio, I, García-Sancho, A, Barba, P. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. Hemasphere. 2025; 9(2)DOI:10.1002/hem3.70077. PMID:39906687. IF:14.600(Q1/1D).
04/02/2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Cortellini, A, Brunetti, L, Di Fazio, GR, Garbo, E, Pinato, DJ, Naidoo, J, Katz, A, Loza, M, Neal, JW, Genova, C, Gettinger, S, Kim, SY, Jayakrishnan, R, El Zarif, T, Russano, M, Pecci, F, Di Federico, A, Awad, M, Alessi, J, Montrone, M, Owen, DH, Signorelli, D, Fidler, MJ, Li, MJ, Camerini, A, De Giglio, A, Young, L, Vincenzi, B, Metro, G, Passiglia, F, Yendamuri, S, Guida, A, Ghidini, M, Awosika, NO, Napolitano, A, Fulgenzi, CAM, Grisanti, S, Grossi, F, D'Incecco, A, Josephides, E, Van Hemelrijck, M, Russo, A, Gelibter, A, Spinelli, G, Verrico, M, Tomasik, B, Giusti, R, Newsom-Davis, T, Bria, E, Sebastian, M, Rost, M, Forster, M, Mukherjee, U, Landi, L, Mazzoni, F, Aujayeb, A, Dupont, M, Curioni-Fontecedro, A, Chiari, R, Pantano, F, Morabito, A, Leonetti, A, Friedlaender, A, Addeo, A, Zoratto, F, De Tursi, M, Cantini, L, Roca, E, Mountzios, G, Della Gravara, L, Kalvapudi, S, Inno, A, Bironzo, P, Barros, RD, O'Reilly, D, Bell, J, Karapanagiotou, E, Monnet, I, Baena, J, Macerelli, M, Majem, M, Agustoni, F, Cortinovis, DL, Tonini, G, Minuti, G, Bennati, C, Mezquita, L, Gorría, T, Servetto, A, Beninato, T, Lo Russo, G, Rogado, J, Moliner, L, Biello, F, Nana, FA, Dingemans, AM, Aerts, JGJ, Ferrara, R, Torri, V, Abu Hejleh, T, Takada, K, Naqash, AR, Garassino, M, Peters, S, Wakelee, H, Nassar, AH, Ricciuti, B. Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. Journal for ImmunoTherapy of Cancer. 2025; 13(2)DOI:10.1136/jitc-2024-010674. PMID:39904562. IF:10.600(Q1/1D).
03/02/2025
Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
Puig, L. Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljaf003. PMID:39761694. IF:9.600(Q1/1D).
03/02/2025
Rapid Quantitative Assessment of Muscle Sodium Dynamics After Exercise Using 23Na-MRI in Dysferlinopathy and Healthy Controls
Neal, MA, Bolano-Diaz, CF, Richardson, M, Michell-Sodhi, J, Muni-Lofra, R, James, MK, Hollingsworth, KG, Hilsden, H, Wilson, I, Blamire, AM, Straub, V, Thelwall, PE, Diaz-Manera, J. Rapid Quantitative Assessment of Muscle Sodium Dynamics After Exercise Using 23Na-MRI in Dysferlinopathy and Healthy Controls. Journal of Cachexia Sarcopenia and Muscle. 2025; 16(1)DOI:10.1002/jcsm.13709. PMID:39900102. IF:9.100(Q1/1D).